Wilmington PharmaTech Names Veteran Exec to Lead Commercial Push

Wilmington PharmaTech

NEWARK, DE — Wilmington PharmaTech said it has appointed Mike Shearer as chief commercial officer, tasking the longtime pharmaceutical services executive with driving growth, expanding client relationships, and strengthening the company’s position in active pharmaceutical ingredient development and manufacturing.

Shearer will report to Hui-Yin “Harry” Li, founder and chief executive officer of Wilmington PharmaTech.

The appointment comes as demand increases for U.S.-based API manufacturing and high-potency supply, areas where Wilmington PharmaTech has been expanding its capabilities. The company operates from a recently expanded campus in Wilmington, Delaware.

“Having worked with Mike for more than two decades, I know that, beyond his track record of excellent commercial execution, he brings a strategic, client-centric approach to every engagement,” said Kent Payne, managing director at Wilmington PharmaTech and an operating partner at Curewell Capital. Payne said Shearer’s leadership will support the company’s efforts to meet evolving industry needs while positioning it for future growth.

READ:  Faith Meets Finance as Podcast Marks 1,000 Episodes of Steady Growth

Shearer brings more than 24 years of experience across contract development and manufacturing organizations and pharmaceutical services companies. Before joining Wilmington PharmaTech, he spent more than two decades at Catalent, where he held a series of senior leadership roles. Most recently, he served as vice president of Rx early phase development and Zydis, overseeing global commercial teams and supporting advanced drug delivery programs.

In that role, Shearer led cross-functional teams across multiple regions and helped develop commercial strategies aimed at long-term growth, the company said.

READ:  Nuevocor Taps Veteran Biotech Leader as It Nears First Human Trials

“I am excited to join WPT’s deeply experienced leadership team to focus on the company’s next phase of growth with the support of Curewell Capital,” Shearer said. He cited the company’s chemistry expertise and flexible manufacturing infrastructure as key strengths.

Shearer holds a bachelor’s degree from Drexel University in Philadelphia and a master’s degree from the University of California, Davis.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.